Status: Recruiting
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
The purpose of the study is to enable participants with pulmonary hypertension (PH) currently treated with study intervention(s) in a clinical study (parent studies \[NCT03422328, NCT03904693,NCT04565990, NCT02932410, NCT03492177, and NCT04175600\]), to continue to benefit from the intervention after closure of the parent study in case they have no alternative means of access to the study intervention. This study will allow assessment of the long-term safety of each study intervention.
Participants needed: 280
Trial details
Phase: Phase 3Age: 2+Biological sex: AllType: InterventionalSponsor: ActelionUpdated: Jun 5, 2026Locations: 45
Eligibility criteria
Participant must sign an informed consent form (ICF) (or their legally designate... [+2]
Participants prematurely discontinued from the study intervention in their paren... [+17]